What is he best known for?
The fields of study he is best known for:
- Gene
- Genetics
- Internal medicine
His primary scientific interests are in Genetics, Gastrointestinal Microbiome, Metagenomics, Genome-wide association study and Quantitative trait locus.
His study explores the link between Genetics and topics such as Internal medicine that cross with problems in Cardiology.
Jingyuan Fu has included themes like Clostridium difficile, Enterococcus, Cohort study, Immune system and Dysbiosis in his Gastrointestinal Microbiome study.
His Metagenomics research incorporates themes from Microbiome, Immunology and Heritability.
His Genome-wide association study study combines topics from a wide range of disciplines, such as Linkage disequilibrium, Genetic association and Locus.
As a part of the same scientific family, Jingyuan Fu mostly works in the field of Quantitative trait locus, focusing on Expression quantitative trait loci and, on occasion, Genetic variation.
His most cited work include:
- Population-level analysis of gut microbiome variation (903 citations)
- Environment dominates over host genetics in shaping human gut microbiota (861 citations)
- Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity. (778 citations)
What are the main themes of his work throughout his whole career to date?
Jingyuan Fu mainly investigates Genetics, Microbiome, Immunology, Genome-wide association study and Gut flora.
His study in Quantitative trait locus, Genetic variation, Single-nucleotide polymorphism, Expression quantitative trait loci and Gene falls within the category of Genetics.
The Microbiome study which covers Metagenomics that intersects with Bacterial genetics.
His study in Immunology is interdisciplinary in nature, drawing from both Phenotype and Inflammatory bowel disease.
Jingyuan Fu works mostly in the field of Genome-wide association study, limiting it down to concerns involving Disease and, occasionally, Obesity.
His research integrates issues of Internal medicine, Cohort, Feces and Metabolomics in his study of Gut flora.
He most often published in these fields:
- Genetics (36.91%)
- Microbiome (30.87%)
- Immunology (24.83%)
What were the highlights of his more recent work (between 2019-2021)?
- Microbiome (30.87%)
- Genetics (36.91%)
- Immunology (24.83%)
In recent papers he was focusing on the following fields of study:
Jingyuan Fu mainly focuses on Microbiome, Genetics, Immunology, Gut microbiome and Metagenomics.
He combines subjects such as Gut flora, Human virome, Gluten free and Metabolism with his study of Microbiome.
His Gut flora research includes themes of Drug and Bioinformatics.
His work on Immune system as part of general Immunology study is frequently linked to Context, therefore connecting diverse disciplines of science.
His Metagenomics research focuses on subjects like Irritable bowel syndrome, which are linked to Polypharmacy.
His Genome-wide association study research integrates issues from Genetic variation, Locus and Genomics.
Between 2019 and 2021, his most popular works were:
- Impact of commonly used drugs on the composition and metabolic function of the gut microbiota (87 citations)
- Interaction between drugs and the gut microbiome (29 citations)
- Metabolomics Profile in Depression: A Pooled Analysis of 230 Metabolic Markers in 5283 Cases With Depression and 10,145 Controls (26 citations)
In his most recent research, the most cited papers focused on:
- Gene
- Internal medicine
- Genetics
His main research concerns Disease, Genome-wide association study, Microbiome, Immunology and Context.
His Disease study deals with Gene intersecting with Meta-analysis and Signal transduction.
His Genome-wide association study study deals with the bigger picture of Genetics.
Jingyuan Fu has researched Microbiome in several fields, including Gut flora and Drug.
His work deals with themes such as Abundance, Genetic predisposition, Cohort study, Phenotype and Single-nucleotide polymorphism, which intersect with Immunology.
In his study, which falls under the umbrella issue of Abundance, Irritable bowel syndrome, Polypharmacy and Metagenomics is strongly linked to Cohort.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
